We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Trinity Biotech Plc | TG:TRB | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
Hot Features
Premium
RNS Number:1481O
Tribal Group PLC
30 July 2003
Tribal Group plc ('the Company')
Tribal Group plc were advised on 24 July 2003 by Aviva plc that Morley Fund
Management Limited (a subsidiary of Aviva plc) has a notifiable interest in
2,528,442 ordinary shares in the Company, representing 3.96% of its issued
ordinary share capital.
Aviva plc also hold an interest in these shares.
These shares are held as follows:
Registered holders Number of shares held
BNY Norwich Union Nominees Ltd 248,736
Chase GA Group Nominees Ltd 1,727,364
Chase Nominees Ltd 96,478
CUIM Nominee Ltd 333,699
RBSTB Nominees Ltd 122,165
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFGGFNKGZGFZM
1 Year Trinity Biotech Chart |
1 Month Trinity Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
